|
Name |
decaturin C
|
| Molecular Formula | C30H35NO5 | |
| IUPAC Name* |
(1S,2R,6S,7R,10R,12S)-12-hydroxy-5,7,11,11-tetramethyl-6'-pyridin-3-ylspiro[13-oxatetracyclo[10.2.2.01,10.02,7]hexadec-4-ene-6,2'-3H-furo[3,2-c]pyran]-4'-one
|
|
| SMILES |
CC1=CC[C@H]2[C@]([C@]13CC4=C(O3)C=C(OC4=O)C5=CN=CC=C5)(CC[C@@H]6[C@]27CC[C@@](C6(C)C)(OC7)O)C
|
|
| InChI |
InChI=1S/C30H35NO5/c1-18-7-8-24-27(4,10-9-23-26(2,3)30(33)12-11-28(23,24)17-34-30)29(18)15-20-22(36-29)14-21(35-25(20)32)19-6-5-13-31-16-19/h5-7,13-14,16,23-24,33H,8-12,15,17H2,1-4H3/t23-,24-,27+,28+,29-,30-/m0/s1
|
|
| InChIKey |
VVYVYDOUCPUFSI-XHVWOXFNSA-N
|
|
| Synonyms |
decaturin C; CHEMBL517063
|
|
| CAS | NA | |
| PubChem CID | 21593948 | |
| ChEMBL ID | CHEMBL517063 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 489.6 | ALogp: | 4.1 |
| HBD: | 1 | HBA: | 6 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 77.9 | Aromatic Rings: | 8 |
| Heavy Atoms: | 36 | QED Weighted: | 0.529 |
| Caco-2 Permeability: | -5.064 | MDCK Permeability: | 0.00001760 |
| Pgp-inhibitor: | 0.632 | Pgp-substrate: | 0.002 |
| Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.136 |
| 30% Bioavailability (F30%): | 0.514 |
| Blood-Brain-Barrier Penetration (BBB): | 0.548 | Plasma Protein Binding (PPB): | 94.57% |
| Volume Distribution (VD): | 2.62 | Fu: | 5.03% |
| CYP1A2-inhibitor: | 0.261 | CYP1A2-substrate: | 0.889 |
| CYP2C19-inhibitor: | 0.72 | CYP2C19-substrate: | 0.624 |
| CYP2C9-inhibitor: | 0.843 | CYP2C9-substrate: | 0.084 |
| CYP2D6-inhibitor: | 0.063 | CYP2D6-substrate: | 0.392 |
| CYP3A4-inhibitor: | 0.947 | CYP3A4-substrate: | 0.585 |
| Clearance (CL): | 10.307 | Half-life (T1/2): | 0.164 |
| hERG Blockers: | 0.56 | Human Hepatotoxicity (H-HT): | 0.489 |
| Drug-inuced Liver Injury (DILI): | 0.227 | AMES Toxicity: | 0.006 |
| Rat Oral Acute Toxicity: | 0.13 | Maximum Recommended Daily Dose: | 0.919 |
| Skin Sensitization: | 0.161 | Carcinogencity: | 0.179 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
| Respiratory Toxicity: | 0.947 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002080 | ![]() |
0.776 | D02STN | ![]() |
0.311 | ||
| ENC002102 | ![]() |
0.746 | D06CNP | ![]() |
0.303 | ||
| ENC003423 | ![]() |
0.724 | D04GJN | ![]() |
0.241 | ||
| ENC003422 | ![]() |
0.709 | D0Z1XD | ![]() |
0.235 | ||
| ENC002118 | ![]() |
0.695 | D09IPV | ![]() |
0.227 | ||
| ENC003611 | ![]() |
0.588 | D0U3GL | ![]() |
0.226 | ||
| ENC002410 | ![]() |
0.515 | D0V4WD | ![]() |
0.224 | ||
| ENC002411 | ![]() |
0.496 | D0I2SD | ![]() |
0.223 | ||
| ENC005020 | ![]() |
0.470 | D08QKJ | ![]() |
0.223 | ||
| ENC002192 | ![]() |
0.459 | D0L2LS | ![]() |
0.219 | ||